Search - tctmd.com

Displaying 101 - 114 of 114

Sort: Relevancy | Date

News Conference News ISC 2017

Restarting Oral Anticoagulation After Intracerebral Hemorrhage Tied to Better Outcomes

Todd Neale

February 27, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

News Daily News

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Todd Neale

February 16, 2017

News Daily News

AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants

Yael L. Maxwell

February 13, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

Caitlin E. Cox

February 01, 2017

News Daily News

Unique Scar in RVOT May Trigger Ventricular Tachycardia Seen in High-Level Endurance Athletes

Michael O'Riordan

January 31, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Daily News

FDA Warns of Cybersecurity Holes in Certain Cardiac Devices and Monitoring System

Yael L. Maxwell

January 09, 2017

News Daily News

Interrupting Anticoagulation? New Guidance Aims to Simplify Periprocedural Decision-Making

Todd Neale

January 09, 2017

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Shelley Wood

January 04, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Presentation

Apixaban in Patients With Atrial Fibrillation After TAVR

Presenter: J. Seeger

January 03, 2017

Advertisement

Restarting Oral Anticoagulation After Intracerebral Hemorrhage Tied to Better Outcomes

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants

TCTMD’s Top 10 Most Popular Stories for January 2017

Unique Scar in RVOT May Trigger Ventricular Tachycardia Seen in High-Level Endurance Athletes

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

FDA Warns of Cybersecurity Holes in Certain Cardiac Devices and Monitoring System

Interrupting Anticoagulation? New Guidance Aims to Simplify Periprocedural Decision-Making

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Apixaban in Patients With Atrial Fibrillation After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content